Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Goldberg, J. F. Articles by Sachs, G. S. Search for Related Content PubMed Citation Articles by Goldberg, J. F. Articles by Sachs, G. S. Bipolar Disorder Outpatient Services Suicide Related Article

Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients

OBJECTIVE: Little is known about the effects of lithium on suicidal ideation or about the possible antisuicidal effects of divalproex, second-generation antipsychotics, or antidepressants among persons with bipolar disorder. METHODS: Using a cross-sectional design, the authors examined patterns of psychotropic drug use relative to suicidal ideation among 1,000 patients with bipolar disorder in the National Institute of Mental Health's Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). RESULTS: The presence of suicidal ideation was similar between patients who were taking any lithium and those who were not (22.2 percent and 25.8 percent, respectively) and between those who were taking any divalproex and those who were not (20.3 percent and 21.5 percent). Suicidal ideation was significantly more prevalent among patients who were taking a second-generation antipsychotic than those who were not (26 percent and 17 percent) and those who were taking an antidepressant and those who were not (25 percent and 14 percent). After other variables had been controlled for, lithium prescriptions were significantly more common among patients who had suicidal ideation. CONCLUSIONS: Among patients with bipolar disorder who have suicidal ideation, antidepressants and second-generation antipsychotics appear to be prescribed by community practitioners more often than other medications, with lithium reserved for those with more severe illness characteristics.

Related Article:

December 2005: This Month's Highlights
Psychiatr Serv 2005 56: 1490. [Full Text] [PDF]

This article has been cited by other articles:

				T. R. Insel Translating Scientific Opportunity Into Public Health Impact: A Strategic Plan for Research on Mental Illness Arch Gen Psychiatry, February 1, 2009; 66(2): 128 - 133. [Abstract] [Full Text] [PDF]

				G. S. Sachs, A. A. Nierenberg, J. R. Calabrese, L. B. Marangell, S. R. Wisniewski, L. Gyulai, E. S. Friedman, C. L. Bowden, M. D. Fossey, M. J. Ostacher, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression N. Engl. J. Med., April 26, 2007; 356(17): 1711 - 1722. [Abstract] [Full Text] [PDF]

				Bibliography PSYCHOPHARMACOLOGY Focus, September 1, 2006; 4(4): 512. [Full Text] [PDF]

				J. F. Goldberg, M. H. Allen, D. A. Miklowitz, C. L. Bowden, C. J. Endick, C. A. Chessick, S. R. Wisniewski, S. Miyahara, K. Sagduyu, M. E. Thase, et al. Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients Focus, September 1, 2006; 4(4): 565. [Full Text] [PDF]

				J. Rosack Lithium Often Takes Backseat To Other Bipolar Therapies Psychiatr News, March 3, 2006; 41(5): 33 - 33. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us